XRAY — DENTSPLY SIRONA Income Statement
0.000.00%
Last trade - 00:00
- $6.35bn
- $8.13bn
- $3.97bn
- 50
- 36
- 58
- 46
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K/A | 10-K/A | 10-K/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,022 | 3,339 | 4,231 | 3,922 | 3,965 |
Cost of Revenue | |||||
Gross Profit | 2,189 | 1,700 | 2,344 | 2,127 | 2,090 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,670 | 3,342 | 3,623 | 4,862 | 4,050 |
Operating Profit | 352 | -3 | 608 | -940 | -85 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 338 | -50 | 545 | -1,055 | -175 |
Provision for Income Taxes | |||||
Net Income After Taxes | 256 | -73 | 411 | -950 | -132 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 256 | -73 | 411 | -950 | -132 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 256 | -73 | 411 | -950 | -132 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.58 | 0.497 | 1.93 | -0.475 | 0.546 |
Dividends per Share |